Effect of Vitamin D in Addition to Letrozole on the Ovulation Rate of Women with Polycystic Ovary Syndrome: Protocol of a Multicentre Randomised Double-blind Controlled Trial

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 Apr 29

PMID 38684265

Authors

Jennifer K Y Ko

Sofie S F Yung

Shui Fan Lai

Rebecca S F Wan

Catherine K Y Wong

Keedon Wong

Ching-Lung Cheung

Ernest H Y Ng

Raymond H W Li

Affiliations

Soon will be listed here.

Abstract

Introduction: Low vitamin D status is prevalent among women with polycystic ovary syndrome (PCOS). The objective of the study is to assess the effect of vitamin D supplementation on (1) the ovulation rate to letrozole and (2) other reproductive, endocrine and metabolic outcomes after 1 year of supplementation in women with PCOS.

Methods And Analysis: This is a multicentre, randomised, double-blind, controlled clinical trial. A total of 220 anovulatory women with PCOS diagnosed by the Rotterdam criteria will be recruited. They will be randomly assigned to either the (1) vitamin D supplementation group or (2) placebo group. Those in the vitamin D group will take oral Vitamin D3 50 000 IU/week for 4 weeks, followed by 50 000 IU once every 2 weeks for 52 weeks. Those who remain anovulatory after 6 months will be treated with a 6-month course of letrozole (2.5 mg to 7.5 mg for 5 days per cycle titrated according to response) for ovulation induction. The primary outcome is the ovulation rate. All statistical analyses will be performed using intention-to-treat and per protocol analyses.

Ethics And Dissemination: Ethics approval was sought from the Institutional Review Board of the participating units. All participants will provide written informed consent before joining the study. The results of the study will be submitted to scientific conferences and peer-reviewed journals.

Trial Registration Number: NCT04650880.

References

Palacios C, Gonzalez L . Is vitamin D deficiency a major global public health problem?. J Steroid Biochem Mol Biol. 2013; 144 Pt A:138-45. PMC: 4018438. DOI: 10.1016/j.jsbmb.2013.11.003. View

Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S . Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003; 88(12):5957-62. DOI: 10.1210/jc.2003-030727. View

Al-Daghri N, Amer O, Khattak M, Sabico S, Ansari M, Al-Saleh Y . Effects of different vitamin D supplementation strategies in reversing metabolic syndrome and its component risk factors in adolescents. J Steroid Biochem Mol Biol. 2019; 191:105378. DOI: 10.1016/j.jsbmb.2019.105378. View

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View

Mogili K, Karuppusami R, Thomas S, Chandy A, Kamath M, Tk A . Prevalence of vitamin D deficiency in infertile women with polycystic ovarian syndrome and its association with metabolic syndrome - A prospective observational study. Eur J Obstet Gynecol Reprod Biol. 2018; 229:15-19. DOI: 10.1016/j.ejogrb.2018.08.001. View

Xue Y, Xu P, Xue K, Duan X, Cao J, Luan T . Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis. Arch Gynecol Obstet. 2016; 295(2):487-496. DOI: 10.1007/s00404-016-4247-y. View

Azadi-Yazdi M, Nadjarzadeh A, Khosravi-Boroujeni H, Salehi-Abargouei A . The Effect of Vitamin D Supplementation on the Androgenic Profile in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials. Horm Metab Res. 2017; 49(3):174-179. DOI: 10.1055/s-0043-103573. View

J Malloy P, Peng L, Wang J, Feldman D . Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology. 2008; 150(4):1580-7. PMC: 2659287. DOI: 10.1210/en.2008-1555. View

Fang F, Ni K, Cai Y, Shang J, Zhang X, Xiong C . Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract. 2017; 26:53-60. DOI: 10.1016/j.ctcp.2016.11.008. View

10.

Irani M, Minkoff H, Seifer D, Merhi Z . Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocrinol Metab. 2014; 99(5):E886-90. DOI: 10.1210/jc.2013-4374. View

11.

Wu X, Wang Y, Liu J, Liang R, Xue H, Ma H . Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertil Steril. 2016; 106(3):757-765.e1. DOI: 10.1016/j.fertnstert.2016.05.022. View

12.

Kawahara T, Suzuki G, Mizuno S, Inazu T, Kasagi F, Kawahara C . Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population. BMJ. 2022; 377:e066222. PMC: 9131780. DOI: 10.1136/bmj-2021-066222. View

13.

Wathen N, Perry L, Lilford R, Chard T . Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed). 1984; 288(6410):7-9. PMC: 1444184. DOI: 10.1136/bmj.288.6410.7. View

14.

Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L . Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018; 33(9):1602-1618. PMC: 6112576. DOI: 10.1093/humrep/dey256. View

15.

Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick E, Mann V, Corless L . A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients. 2019; 11(1). PMC: 6356309. DOI: 10.3390/nu11010188. View

16.

Karadag C, Yoldemir T, Yavuz D . Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients. J Obstet Gynaecol Res. 2017; 44(2):270-277. DOI: 10.1111/jog.13516. View

17.

Lagowska K, Bajerska J, Jamka M . The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018; 10(11). PMC: 6266903. DOI: 10.3390/nu10111637. View

18.

Ostadmohammadi V, Milajerdi A, Ghayour-Mobarhan M, Ferns G, Taghizadeh M, Badehnoosh B . The Effects of Vitamin D Supplementation on Glycemic Control, Lipid Profiles and C-Reactive Protein Among Patients with Cardiovascular Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Pharm Des. 2019; 25(2):201-210. DOI: 10.2174/1381612825666190308152943. View

19.

Butts S, Seifer D, Koelper N, Senapati S, Sammel M, Hoofnagle A . Vitamin D Deficiency Is Associated With Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility. J Clin Endocrinol Metab. 2018; 104(2):369-378. PMC: 6300410. DOI: 10.1210/jc.2018-00750. View

20.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View